In order to pursue DPP4 targeted therapy as an alternative to treat IPF or other fibrotic lung diseases, understanding DPP4 involvement at earlier stages of the disease would be desirable. This evidence concerns the gene DPP4 and idiopathic pulmonary fibrosis.